Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59).

Azuma KanatsukaYasunori SatoYoichiro HigashiYoshimasa GotoKoichi KawaiHiroshi Maegawanull null

Published in: Journal of diabetes investigation (2021)

The combination of disease duration-to-age at diagnosis and HbA1c-to-CPR ratios is a collective risk factor that predicts response to the medications.

Keyphrases

type diabetes
cardiac arrest
risk factors
cardiovascular disease
healthcare
case report
emergency department
cardiopulmonary resuscitation
blood pressure
metabolic syndrome
blood glucose
red blood cell
weight loss